4/28/2022 1:35:11 AM
Sanofi Q1 Business EPS EUR 1.94; IFRS EPS EUR 1.61
4/13/2022 5:11:17 AM
Sempre Health Says Collaboration With Sanofi Supports Companies' Joint Focus On Medication Adherence And Affordability
4/7/2022 1:01:23 AM
Regeneron Pharma And Sanofi: EC Expands Marketing Authorization For Dupixent In The European Union
4/1/2022 1:39:28 AM
Sanofi Expects EUROAPI First Day Of Trading On Euronext Paris To Occur On May 6, 2022
3/28/2022 8:04:14 AM
Sanofi : Canada Oks Dupixent To Treat Severe Asthma In Children Aged Six To 11 Years With Type 2 Inflammation
3/28/2022 3:44:24 AM
Sanofi Says Japan's MHLW Grants Marketing Authorization For Xenpozyme
3/18/2022 8:35:50 AM
Sanofi's EUROAPI Listing On Euronext Paris
3/16/2022 6:36:51 AM
Seagen And Sanofi Collaborate To Commercialize Multiple Novel Antibody-Drug Conjugates For Up To Three Cancer Targets
3/15/2022 2:24:43 AM
Sanofi Announces EUR 300 Mln Collaboration With Blackstone Life Sciences To Accelerate Clinical Program Of Sarclisa